Related Experiment Videos
Atherosclerotic heart disease in the elderly
1Department of Medicine, New York University School of Medicine, New York 10016, USA.
Current Opinion in Cardiology
|July 1, 1995
Summary
Elderly patients with ischemic heart disease often have complex conditions and poorer outcomes. Standard treatments like medications and revascularization are underused in this growing population.
Area of Science:
- Cardiology
- Geriatrics
- Internal Medicine
Background:
- Elderly patients are a significant and growing population with ischemic heart disease.
- Aging is associated with cardiovascular changes, increasing comorbidity and atypical presentations.
- These factors contribute to poorer outcomes in older adults with ischemic heart disease.
Purpose of the Study:
- To highlight the challenges and considerations for treating ischemic heart disease in the elderly.
- To review the current evidence on the use of standard treatments in this demographic.
- To emphasize the underutilization of effective therapies.
Main Methods:
- Review of existing literature and clinical data on ischemic heart disease in elderly patients.
- Analysis of treatment outcomes associated with pharmacologic, thrombolytic, and revascularization strategies.
- Evaluation of factors contributing to the underuse of standard therapies.
Main Results:
- Elderly patients present with higher rates of comorbid conditions and atypical symptoms.
- Standard treatments, including medications, thrombolysis, and revascularization, are effective but underused.
- Age-related cardiovascular changes influence treatment response and outcomes.
Conclusions:
- Ischemic heart disease management in the elderly requires tailored approaches.
- Increased utilization of evidence-based pharmacologic, thrombolytic, and revascularization therapies is crucial.
- Further research is needed to optimize treatment strategies for older adults.